https://www.selleckchem.com/pr....oducts/enfortumab-ve
At present, postprescription monitoring is very poor. Conclusion Aripiprazole has proven efficacy for several indications in children and adolescents. However, its use requires clinical and paraclinical monitoring to assess the occurrence of adverse events that may challenge the benefit/risk ratio. In addition, off-label prescriptions should be limited, as they appear to account for a significant proportion of aripiprazole use worldwide.Objectives The aim of this study was to explore the experience of Saudi participants
Gefällt mir
Kommentar
Teilen
